PRxOVAIL
About PRxOVAIL™

Benign Prostatic
    Hypertrophy (BPH)


How PRxOVAIL Works
Common Questions
Scientific Validation

Printable Articles
Get PRxOVAIL

For immediate
information
or service
please call
888-503-8300.

Click here for more information

PRxOVAIL
PRxOVAIL

A New Safe and Natural Self-Care Solution for Benign Prostatic Hypertrophy (BPH)


Men concerned about, or suffering from, Benign Prostatic Hypertrophy (BPH), or enlarged prostate, have a new tool in their arsenal for fighting this very common condition – the all-natural supplement PRxOVAIL™.

PRxOVAIL is comprised of plant-based, nutrient-like compounds called lignans that naturally bind to, and occupy human hormone receptors on the prostate.

PRxOVAIL may significantly decrease exposure of sensitive prostate tissue to steroidal hormones by competing against them for the same hormonal receptor sites. This biological response is especially significant to the aging male whose natural hormonal balance begins to shift in a direction that may predispose him to a greater risk of prostatic disease.

What is BPH?


Benign Prostatic Hypertrophy (BPH) is a non-cancerous enlargement of the prostate. Symptoms result when the enlargement squeezes the urethra where it runs through the prostate. BPH is the most common of prostate conditions among men. It is estimated that more than 80% of men in the Western world over the age of 45 years would be considered to have some degree of BPH.

A Natural Solution


PRxOVAIL is a guaranteed potency product formulated to provide a physiologic dose of lignans in a single capsule supplement. While a wide variety of lignans exist in nature, those found to be beneficial toward prostatic disease are very specific. It has only been within the recent past that new technology has been developed to isolate, concentrate and purify these specific lignans from natural plant resources. PRxOVAIL has been formulated to provide a physiologic concentration of lignans equivalent to men with an exceptional history of prostate health.

Click here to read the full article